{"date":"2025-07-17","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6493-2025-07-17-2146-12wbbew","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-07-17","time":"21:46:15","subject":"公告本公司114年現金增資催繳股款相關事宜","clause":"第44款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-07-17 21:46，「公告本公司114年現金增資催繳股款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-07-17-1905-gu161n","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-07-17","time":"19:05:32","subject":"(補充公告)本公司控股子公司FBD與上海復宏漢霖生物技術股份有限公司簽訂抗癌生物新藥HCB101中國大陸、港澳、東南亞特定國家，及所有MENA地區國家市場獨家授權合約。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-07-17 19:05，「(補充公告)本公司控股子公司FBD與上海復宏漢霖生物技術股份有限公司簽訂抗癌生物新藥HCB101中國大陸、港澳、東南亞特」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-07-17-1737-1qqu88n","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-17","time":"17:37:07","subject":"本公司自主開發免疫調控多重激酉每抑制劑GNTbm-TKI的研究摘要，已獲選將於2025年歐洲腫瘤醫學學會(ESMO)年會以海報形式發表","clause":"第44款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-07-17 17:37，「本公司自主開發免疫調控多重激酉每抑制劑GNTbm-TKI的研究摘要，已獲選將於2025年歐洲腫瘤醫學學會(ESMO)年會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-07-17-1734-1j46v82","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-07-17","time":"17:34:10","subject":"公告本公司現金股利除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-07-17 17:34，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-07-17-1707-w1hkkn","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-07-17","time":"17:07:20","subject":"公告本公司簽訂竹北廠統包工程興建契約","clause":"第17款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-07-17 17:07，「公告本公司簽訂竹北廠統包工程興建契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-07-17-1626-d1ks3o","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-07-17","time":"16:26:42","subject":"公告本公司114年第二季合併財務報告預計提報董事會日期","clause":"第31款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-07-17 16:26，「公告本公司114年第二季合併財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-07-17-1602-bg1p0i","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-07-17","time":"16:02:21","subject":"代重要子公司TBG Diagnostics Ltd.公告股東會召開事宜","clause":"第17款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-07-17 16:02，「代重要子公司TBG Diagnostics Ltd.公告股東會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-07-17-1601-nhzt8w","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-17","time":"16:01:04","subject":"公告本公司註銷限制員工權利新股變更登記完成","clause":"第35款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-07-17 16:01，「公告本公司註銷限制員工權利新股變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-07-17-1534-r8eodx","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-07-17","time":"15:34:35","subject":"公告本公司114年第二季個別財務報告預計提報董事會日期","clause":"第31款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-07-17 15:34，「公告本公司114年第二季個別財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-07-17-1521-54swv6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-07-17","time":"15:21:43","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-07-17 15:21，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-07-17-1454-1h79e5u","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-07-17","time":"14:54:04","subject":"本公司二廠(新廠)未取得國產醫療器材品質管理系統(QMS)資格","clause":"第53款","fact_date":"2025-07-17","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-07-17 14:54，「本公司二廠(新廠)未取得國產醫療器材品質管理系統(QMS)資格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}